Cui, Q., Hu, Y., Ma, D., & Liu, H. (2021). A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. Drug Des Devel Ther.
Citação norma ChicagoCui, Qingli, Yanhui Hu, Dongyang Ma, and Huaimin Liu. "A Retrospective Observational Study of Anlotinib in Patients With Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer." Drug Des Devel Ther 2021.
Citação norma MLACui, Qingli, Yanhui Hu, Dongyang Ma, and Huaimin Liu. "A Retrospective Observational Study of Anlotinib in Patients With Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer." Drug Des Devel Ther 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.